These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. VSMC-Specific Deletion of FAM3A Attenuated Ang II-Promoted Hypertension and Cardiovascular Hypertrophy. Xiang R; Chen J; Li S; Yan H; Meng Y; Cai J; Cui Q; Yang Y; Xu M; Geng B; Yang J Circ Res; 2020 Jun; 126(12):1746-1759. PubMed ID: 32279581 [TBL] [Abstract][Full Text] [Related]
5. The GTPase ARF6 Controls ROS Production to Mediate Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation. Bourmoum M; Charles R; Claing A PLoS One; 2016; 11(1):e0148097. PubMed ID: 26824355 [TBL] [Abstract][Full Text] [Related]
6. Loss of epidermal growth factor receptor in vascular smooth muscle cells and cardiomyocytes causes arterial hypotension and cardiac hypertrophy. Schreier B; Rabe S; Schneider B; Bretschneider M; Rupp S; Ruhs S; Neumann J; Rueckschloss U; Sibilia M; Gotthardt M; Grossmann C; Gekle M Hypertension; 2013 Feb; 61(2):333-40. PubMed ID: 23248150 [TBL] [Abstract][Full Text] [Related]
7. Transactivation of epidermal growth factor receptor by enhanced levels of endogenous angiotensin II contributes to the overexpression of Giα proteins in vascular smooth muscle cells from SHR. Sandoval YH; Li Y; Anand-Srivastava MB Cell Signal; 2011 Nov; 23(11):1716-26. PubMed ID: 21712088 [TBL] [Abstract][Full Text] [Related]
8. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease. Marchesi C; Rehman A; Rautureau Y; Kasal DA; Briet M; Leibowitz A; Simeone SM; Ebrahimian T; Neves MF; Offermanns S; Gonzalez FJ; Paradis P; Schiffrin EL Cardiovasc Res; 2013 Mar; 97(3):562-70. PubMed ID: 23250918 [TBL] [Abstract][Full Text] [Related]
9. Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells. Yoshimoto T; Fukai N; Sato R; Sugiyama T; Ozawa N; Shichiri M; Hirata Y Endocrinology; 2004 Jul; 145(7):3331-7. PubMed ID: 15070851 [TBL] [Abstract][Full Text] [Related]
10. Consequences of epidermal growth factor receptor (ErbB1) loss for vascular smooth muscle cells from mice with targeted deletion of ErbB1. Schreier B; Döhler M; Rabe S; Schneider B; Schwerdt G; Ruhs S; Sibilia M; Gotthardt M; Gekle M; Grossmann C Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1643-52. PubMed ID: 21512163 [TBL] [Abstract][Full Text] [Related]
11. Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7. Li Y; Li H; Xing W; Li J; Du R; Cao D; Wang Y; Yang X; Zhong G; Zhao Y; Sun W; Liu C; Gao X; Li Y; Liu Z; Jin X; Zhao D; Tan Y; Wang Y; Liu S; Yuan M; Song J; Chang YZ; Gao F; Ling S; Li Y FASEB J; 2021 Nov; 35(11):e21947. PubMed ID: 34637552 [TBL] [Abstract][Full Text] [Related]
12. Contribution of epidermal growth factor receptor transactivation in angiotensin II-induced enhanced expression of Gi protein and proliferation in A10 vascular smooth muscle cells. Gomez Sandoval YH; Lévesque LO; Anand-Srivastava MB Can J Physiol Pharmacol; 2009 Dec; 87(12):1037-45. PubMed ID: 20029540 [TBL] [Abstract][Full Text] [Related]
14. Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, alphavbeta3-integrin, and TGF-beta1 in response to ANG II and high glucose. Belmadani S; Zerfaoui M; Boulares HA; Palen DI; Matrougui K Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H69-76. PubMed ID: 18456735 [TBL] [Abstract][Full Text] [Related]
15. Fibroblast Nox2 (NADPH Oxidase-2) Regulates ANG II (Angiotensin II)-Induced Vascular Remodeling and Hypertension via Paracrine Signaling to Vascular Smooth Muscle Cells. Harrison CB; Trevelin SC; Richards DA; Santos CXC; Sawyer G; Markovinovic A; Zhang X; Zhang M; Brewer AC; Yin X; Mayr M; Shah AM Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):698-710. PubMed ID: 33054395 [TBL] [Abstract][Full Text] [Related]